BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1541668)

  • 1. Characterization of the immunoglobulin heavy chain complementarity determining region (CDR)-III sequences from human B cell precursor acute lymphoblastic leukemia cells.
    Kiyoi H; Naoe T; Horibe K; Ohno R
    J Clin Invest; 1992 Mar; 89(3):739-46. PubMed ID: 1541668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of immunoglobulin heavy chain variable region genes in childhood B-cell acute lymphoblastic leukemia].
    Liu Y; Zhu P; Hu YM
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):8-12. PubMed ID: 14990068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. At least five DH genes of human immunoglobulin heavy chains are encoded in 9-kilobase DNA fragments.
    Ichihara Y; Abe M; Yasui H; Matsuoka H; Kurosawa Y
    Eur J Immunol; 1988 Apr; 18(4):649-52. PubMed ID: 3130268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of somatic hypermutation of immunoglobulin heavy chain variable region genes in precursor B-lymphoblastic lymphoma: a study of four cases in childhood and adolescence.
    Hojo H; Sasaki Y; Nakamura N; Abe M
    Am J Clin Pathol; 2001 Nov; 116(5):673-82. PubMed ID: 11710683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B precursor acute lymphoblastic leukemia third complementarity-determining regions predominantly represent an unbiased recombination repertoire: leukemic transformation frequently occurs in fetal life.
    Steenbergen EJ; Verhagen OJ; van Leeuwen EF; Behrendt H; Merle PA; Wester MR; von dem Borne AE; van der Schoot CE
    Eur J Immunol; 1994 Apr; 24(4):900-8. PubMed ID: 8149961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of immunoglobulin genes in primary intraocular lymphoma.
    Coupland SE; Hummel M; Müller HH; Stein H
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3507-14. PubMed ID: 16186327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias.
    Deane M; Norton JD
    Eur J Immunol; 1990 Oct; 20(10):2209-17. PubMed ID: 1700749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential usage of JH2 in D-J joinings with DQ52 is determined by the primary DNA sequence and is largely dependent on recombination signal sequences.
    Suzuki H; Shiku H
    Eur J Immunol; 1992 Sep; 22(9):2225-30. PubMed ID: 1516615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pattern of joining (JH) gene usage in the human IgH chain is established predominantly at the B precursor cell stage.
    Wasserman R; Ito Y; Galili N; Yamada M; Reichard BA; Shane S; Lange B; Rovera G
    J Immunol; 1992 Jul; 149(2):511-6. PubMed ID: 1624797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restricted utilization of germ-line VH3 genes and short diverse third complementarity-determining regions (CDR3) in human fetal B lymphocyte immunoglobulin heavy chain rearrangements.
    Raaphorst FM; Timmers E; Kenter MJ; Van Tol MJ; Vossen JM; Schuurman RK
    Eur J Immunol; 1992 Jan; 22(1):247-51. PubMed ID: 1730252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBL-3 cell line, derived from precursor B-cell lymphoblastic leukemia, lacks somatic hypermutation of immunoglobulin heavy chain variable region genes.
    Hojo H; Sasaki Y; Nakamura N; Sato M; Abe M
    Pediatr Dev Pathol; 2004; 7(3):250-7. PubMed ID: 15022065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the most JH-proximal human Ig H chain V region gene, VH6, in the expressed immune repertoire.
    Varade WS; Marin E; Kittelberger AM; Insel RA
    J Immunol; 1993 Jun; 150(11):4985-95. PubMed ID: 8496600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. V(H) gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia.
    Duke VM; Gandini D; Sherrington PD; Lin K; Heelan B; Amlot P; Mehta AB; Hoffbrand AV; Foroni L
    Haematologica; 2003 Nov; 88(11):1259-71. PubMed ID: 14607755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of Ig V region gene somatic hypermutation in advanced Burkitt's lymphoma.
    Carroll WL; Yu M; Link MP; Korsmeyer SJ
    J Immunol; 1989 Jul; 143(2):692-8. PubMed ID: 2500485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the complementary determining region III of the immunoglobulin heavy chain locus in acute lymphoblastic leukemia in Chilean children.
    Barriga FJ; RisueNo C; Patillo JC; Andrade W; Cabrera ME; Beressi V; Del Borgo P; Salgado C; Becker A; Campbell M; Bertin P
    Leukemia; 1996 Nov; 10(11):1719-23. PubMed ID: 8892674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression.
    Küppers R; Rajewsky K; Hansmann ML
    Eur J Immunol; 1997 Jun; 27(6):1398-405. PubMed ID: 9209491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparable profiles of the immunoglobulin heavy chain complementarity determining region (CDR)-3 in CD5+ and CD5- human cord blood B lymphocytes.
    Kiyoi H; Naito K; Ohno R; Naoe T
    Immunology; 1995 Jun; 85(2):236-40. PubMed ID: 7543877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparable gene structure of the immunoglobulin heavy chain variable region between multiple myeloma and normal bone marrow lymphocytes.
    Kiyoi H; Naito K; Ohno R; Naoe T
    Leukemia; 1996 Nov; 10(11):1804-12. PubMed ID: 8892685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations.
    Tamaru J; Hummel M; Marafioti T; Kalvelage B; Leoncini L; Minacci C; Tosi P; Wright D; Stein H
    Am J Pathol; 1995 Nov; 147(5):1398-407. PubMed ID: 7485402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning of a human immunoglobulin gene fragment containing both VH-D and D-JH rearrangements: implication for VH-D as an intermediate to VH-D-JH formation.
    Shin EK; Matsuda F; Fujikura J; Akamizu T; Sugawa H; Mori T; Honjo T
    Eur J Immunol; 1993 Sep; 23(9):2365-7. PubMed ID: 8370413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.